News

Investors' Alert: Class Action Lawsuit Opportunity with Altimmune

Investors' Alert: Class Action Lawsuit Opportunity with Altimmune

Investors Encouraged to Join Class Action Lawsuit

Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, is advising investors about a newly filed class action lawsuit against Altimmune, Inc. (NASDAQ: ALT). This initiative aims to help those who suffered substantial financial losses while holding Altimmune securities.

Understanding the Class Definition

The class action lawsuit is structured to recover damages for individuals and entities that bought or acquired shares of Altimmune during the defined Class Period, specifically from August 10, 2023, to June 25, 2025. If you fall into this category, it is vital to take action.

How to Participate

Investors who meet the criteria for the class are urged to explore their options by visiting the law firm's official site. This move could potentially connect them with others in similar positions, amplifying their voices and claims in court.

Details of the Lawsuit

The complaint against Altimmune's executives highlights several critical allegations. It states that throughout the Class Period, several materially false and misleading statements were made. Particularly, the company misrepresented the prospects of its Pemvidutide trial results, leading to inflated expectations among investors.

Core Allegations of Misrepresentation

The key claims include accusations that the management failed to disclose important aspects of the IMPACT Phase 2b MASH trial, suggesting that the results would not meet the necessary statistical significance due to a flawed trial design. Furthermore, it was argued that the company presented overly optimistic timelines and outcomes related to the drug's efficacy.

What to Expect Moving Forward

As the class action lawsuit progresses, those wishing to stay informed on the proceedings can access the complete complaint through the law firm's resources. It's also crucial for affected parties to consider the timeline; they must express intent to be lead plaintiffs by October 6, 2025, if interested.

Support for Investors

Investors can be assured that there are no upfront costs involved in joining the class action. This means that any legal fees would only be collected if the case results in a financial recovery, making it a risk-free opportunity for potential claimants.

Why Choose Bronstein, Gewirtz & Grossman?

Bronstein, Gewirtz & Grossman, LLC has built a reputation for excellence in representing investors in Securities Fraud cases. Their extensive track record of recovering significant settlements reflects their commitment and expertise in advocating for investor rights.

Ways to Stay Updated

To stay informed about updates regarding this class action lawsuit, individuals can follow Bronstein, Gewirtz & Grossman on various social media platforms. This is an excellent way to keep abreast of any new developments or insights shared by the firm.

How to Reach Out

For more information or to discuss potential involvement in the class action lawsuit, investors can reach out directly:

Bronstein, Gewirtz & Grossman, LLC
Contact: Peretz Bronstein or Nathan Miller
Phone: 332-239-2660 | Email: info@bgandg.com

Frequently Asked Questions

What is the purpose of the class action lawsuit against Altimmune?

The lawsuit seeks to recover damages for investors who acquired Altimmune securities during the specified Class Period and suffered losses.

How can I determine if I am eligible to join the class action?

If you purchased Altimmune securities between August 10, 2023, and June 25, 2025, you may be eligible to join.

Is there a cost involved in participating in the lawsuit?

No, participating in the lawsuit does not require any out-of-pocket expenses upfront. Legal fees are contingent upon a successful recovery.

Who can I contact for more information about the lawsuit?

For inquiries, you can reach out to Peretz Bronstein or Nathan Miller by calling 332-239-2660.

What should I do if I want to become a lead plaintiff?

If you wish to become a lead plaintiff, you need to express your interest by October 6, 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 62

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 59

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
Frost & Sullivan’s 65 Years Put APAC Growth on Display

Updated Category News Views 95

A Crowded Singapore Room Says Something Singapore did not host a mere anniversary toast on November 18; it hosted a pretty revealing cross-section of the businesses trying to build, secure, cool, connect, finance, and digitize Asia Pacific and MEASA. Frost & Sullivan marked 65 years with its 2026 Best Practices Recognition banquet at Hilton Singapore Orchard, gathering...

Continue Reading
Bybit Adds ANT, but Trading Access Has Real Fine Print

Updated Category News Views 38

Anthropic shares have landed on Bybit Stocks, and the headline is simple enough: eligible customers can trade ANT after the company’s public listing. But this is one of those announcements where the plumbing deserves as much attention as the shiny new ticker. A platform can make access feel effortless right up until a jurisdiction rule, a verification hurdle, or a...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 43

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 36

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 83

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
SoCalGas Data Program Puts Metering Case Into Focus

Updated Category News Views 56

Buried beneath the usual utility-company polish is a pretty sensible idea: find waste before a customer gets walloped by a bill. SoCalGas says its Advanced Meter Analytics program has helped customers avoid an estimated $11 million in unnecessary natural-gas costs since 2019. That is not a number likely to move Sempra’s earnings by itself, and nobody should pretend...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 36

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 70

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading

Top 5 Most Recently Viewed Articles

Flat Glass Market Growth and Future Trends Analysis

Updated Category News Views 256

Overview of the Flat Glass Market The flat glass market is on a remarkable trajectory, currently valued at USD 179.80 billion and poised to soar to USD 280.64 billion in the next few years, reflecting a compound annual growth rate (CAGR) of 8.0%. This growth is predominantly fueled by the booming construction and automotive sectors, coupled with a rising demand for...

Continue Reading
The Everglades Foundation Achieves Historic Fundraising Success

Updated Category News Views 435

Celebrating a Milestone for the Everglades Foundation The Everglades Foundation has achieved a monumental success, surpassing its fundraising target during its inaugural endowment campaign. With a remarkable outpouring of support, the Foundation raised $76 million in gifts and pledges from a dedicated group of 80 donors. This significant achievement ensures the long-term...

Continue Reading
Exploring Government's Generative AI Challenges and Solutions

Updated Category News Views 148

Understanding Government's Generative AI Landscape Government agencies are expressing considerable optimism about the potential of Generative AI (GenAI) technology, even as they face challenges in its implementation. Recent insights highlight that while budgeting for these innovations is high, the actual deployment of GenAI remains behind other industries. Survey findings...

Continue Reading
Key Information for DXC Technology Investors Ahead of Deadline

Updated Category News Views 71

Your Rights as a DXC Technology Investor If you're an investor in DXC Technology Company (NYSE: DXC), it’s important to understand your rights and the ongoing legal issues that could impact you. Bernstein Liebhard LLP, a well-respected law firm, wants to remind all DXC shareholders of a critical deadline that’s approaching. Who Needs to Be Concerned? Do you own shares...

Continue Reading
LM Funding America Inc. Reports Q3 2024 Results and Outlook

Updated Category News Views 115

Business Update and Financial Highlights LM Funding America, Inc. (NASDAQ: LMFA) has recently shared its financial results for the third quarter of 2024. This Tampa-based company focuses on cryptocurrency mining and technological finance solutions, showcasing significant strategic developments in its operations. Bitcoin Holdings and Revenue Performance As of September 30,...

Continue Reading